Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nanotechnological applications to open up new opportunities to treat diseases in 15 years time

19.09.2006
On Friday 15th, the Spanish Nanomedicine Platform (Nanomed Spain) and the European Technology Platform on Nanomedicine presented reports on the current status of nanomedicine in Spain and the strategic lines of action at European level to promote R+D in this field.

Both organizations coincide in emphasising that nanotechnology may have direct applications in medicine by contributing to improvements in health and quality of life, and moreover at a reduced cost. The Spanish report, in addition, estimates that the advances currently being developed in this field will reach the health system in the next fifteen years.

However, in its report entitled “Strategic vision of nanomedicine in Spain”, the Nanomed Spain Platform states that nanomedicine is currently in embryonary stage and that it is necessary to strengthen an industrial sector that allows scientific and technological advances to be transferred to specific applications in the health system.

Josep Samitier, coordinator of the Nanomed Spain Platform, affirmed that “Spain can play a relevant role in the development of this field because it has cutting-edge research centres, industrial and pharmaceutical sectors that are interested in using new technologies, as well as a health care system based on a network of hospitals that performs international basic and clinical research”.

According to the report by the Nanomed Spain Platform, as an innovative sector, nanomedicine requires larges investments, will be developed towards applications which yield a significant benefit and in addition, will respond to the health care issues which until now have not been addressed because of scientific or financial limitations.

In this regard, in its Strategic Research Agenda (SRA), the European Technology Platform on Nanomedicine has defined the priority lines of development in European R+D in nanomedicine for the coming years. These lines focus on cardiovascular diseases, cancer, muscular-skeletal disorders, neurodegenerative diseases, diabetes and bacterial and viral infectious diseases, such as AIDS. According to this report, these priorities have been established because they produce a considerable decrease in the quality of life, have a high social and economic cost and because nanotechnology can contribute to the healing process.

These two reports coincide in three application lines for nanomedicine: diagnosis, drug delivery and regenerative medicine. In the first field, devices or sensors will be developed that allow a faster and more reliable diagnosis in early stages of the disease and at a low cost in most cases, for example, cancer.

Regarding drug delivery, nanotechnological advances will allow the effective introduction of the so-called “personalized therapy”, such as administration of a small dose of a drug to obtain maximum effect; the reduction of secondary effects by means of drugs that act only on the therapeutic target; or the development of new more effective administration routes which are comfortable for the patient, such as the nasal administration of insulin. In this regard, for cancer patients, drug delivery systems will be directed exclusively to cancerous cells, thereby avoiding the secondary effects of present chemotherapy protocols.

Another field for the application of nanotechnology is regenerative medicine, in which it will allow the substitution of cells or tissues that do not work for equivalent ones that do, for example in the case of patients with degenerative diseases; as well as tissue regeneration. In the case of cardiovascular diseases, nanotechnology offers the opportunity to develop intelligent nanobiomaterials for the regeneration of tissues, for example in the case of myocardial infarction.

Susana Herráiz | alfa
Further information:
http://www.pcb.ub.es/homePCB/live/en/o190.asp?nid=1336

More articles from Life Sciences:

nachricht Hunting pathogens at full force
22.03.2017 | Helmholtz-Zentrum für Infektionsforschung

nachricht A 155 carat diamond with 92 mm diameter
22.03.2017 | Universität Augsburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Pulverizing electronic waste is green, clean -- and cold

22.03.2017 | Materials Sciences

Astronomers hazard a ride in a 'drifting carousel' to understand pulsating stars

22.03.2017 | Physics and Astronomy

New gel-like coating beefs up the performance of lithium-sulfur batteries

22.03.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>